Skip to Navigation

Amitava Chattopadhyay


Amitava Chattopadhyay
Emerging Market Multinationals - Amitava Chattopadhyay


Ranbaxy Laboratories Limited: At the Crossroads

Ranbaxy Laboratories Limited: At the Crossroads

 

 

The case describes the challenges facing Ranbaxy, the third largest pharmaceutical company in India, which has set itself the goal of moving from the branded generic space to the greater value added branded pharmaceutical space. It has developed a one-a-day delivery system for ciprofloxacin a widely used antibiotic that is about to go off patent. Having sold the rights for the drug delivery system for markets outside India and the CIS to Bayer, the inventor of ciprofloxacin, Ranbaxy is wondering how it should market this new formulation in the India market in particular.


Teaching Objectives

The case poses several interesting questions. First, how should the one-a-day formulation of ciprofloxacin, to be called Cifran OD in India, be positioned? Ranbaxy currently markets ciprofloxacin under the name of Cifran as a branded generic in India. Should Cifran be discontinued when Cifran OD is launched? How should the Cifran OD positioning be implemented? Should the OD formulation be marketed by Ranbaxy alone or should it be co-marketed in collaboration with other local and global pharmaceutical players? The latter question facilitates an interesting discussion of when and how should one collaborate with competitors.

The case has been used for both MBA and executive audiences. It can be used in an introductory marketing course to highlight the power of good positioning. It can also be used in a course on pharmaceutical marketing or a course on how companies from emerging markets can climb the value added business ladder.



Download PDF


 

  Nov 1, 2003 | Cases




Download PDF



SHARE


 


Recent Tweets



Fri, 07 Jun @ 08:38 pm

#BJP leaders clearly have nothing better to do but say moronic things. What about the #BJPMLA who slapped a woman… https://t.co/02sdidB8H9

via Twitter for Android
Sun, 02 Jun @ 08:12 pm

@realDonaldTrump is a congenital liar, as proven again. So what makes people vote for him? Plain stupidity? Or they… https://t.co/g5HZHPvmZU

via Twitter for Android
Sun, 02 Jun @ 08:08 pm

RT @wef: "We can do it and we will continue to do it." 🔎 Learn more about cleaning up the oceans: https://t.co/tAP38l20pp #india #environ

via Twitter for Android
Sat, 01 Jun @ 11:44 am

@CFLosLibertador is the pass open today?

via Twitter for Android
Sat, 01 Jun @ 11:28 am

Consigned to dung heap, yet unable to untie apron strings to Gandhi family. No desire or ability to rejuvenate. Ind… https://t.co/n8r12MPI63

via Twitter for Android
Sat, 01 Jun @ 03:03 am

This is a crime! A person who put his life on the line for our country is being detained as a foreigner. SHAME! SHA… https://t.co/icJd8t48fU

via Twitter for Android

  Close About Papers Cases Books Teaching Musings Media Gallery Ask Amitava